Sofiva GenomicsLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Sofiva GenomicsLtd has a total shareholder equity of NT$640.7M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$775.8M and NT$135.1M respectively. Sofiva GenomicsLtd's EBIT is NT$2.2M making its interest coverage ratio -9.4. It has cash and short-term investments of NT$123.4M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
NT$0
Borç
| Faiz karşılama oranı | -9.4x |
| Nakit | NT$123.42m |
| Eşitlik | NT$640.72m |
| Toplam yükümlülükler | NT$135.13m |
| Toplam varlıklar | NT$775.84m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14
Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07
A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 6615's short term assets (NT$281.0M) exceed its short term liabilities (NT$89.6M).
Uzun Vadeli Yükümlülükler: 6615's short term assets (NT$281.0M) exceed its long term liabilities (NT$45.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 6615 is debt free.
Borcun Azaltılması: 6615 had no debt 5 years ago.
Borç Kapsamı: 6615 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 6615 has no debt, therefore coverage of interest payments is not a concern.